# LOTEPREDNOL ETABONATE
> **ANDA212080** · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2021-02-10
## Drug
- **FDA Application Number:** ANDA212080
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOTEPREDNOL ETABONATE
- **Generic name:** LOTEPREDNOL ETABONATE
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** GEL
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** SENTISS
- **Manufacturer:** ARMAS PHARMACEUTICALS INC.
- **First approval:** 2021-02-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212080)
---
*AI Analytics · CC0 1.0*